The AZD1222 COVID-19 VACCINE Study will research an investigational vaccine for the prevention of COVID-19, the disease caused by the new coronavirus (SARS-CoV-2). The study is looking at how well the investigational vaccine works and how safe it is.
There is currently no approved vaccine for COVID-19. The investigational vaccine is still in the testing and evaluation phase and is not licensed for use in the general public. In this study, participants will be randomly assigned (by chance) to receive 2 injections of either the investigational vaccine or placebo (4 weeks apart). A placebo looks like the investigational vaccine but contains no active vaccine. There is twice as much chance of receiving the investigational vaccine than of receiving the placebo.
The study is now enrolling volunteers who may be at risk of COVID-19. Approximately 30,000 participants from the United States will take part in this study.
U-M Principal Investigators
Dame Sheila Sherlock Distinguished University Professor
Assistant Dean for Clinical Research
Alice Lohrman Andrews Research Professor of Hepatology
Director of Clinical Hepatology
Department of Internal Medicine
Associate Professor of Internal Medicine
Asthma Program Director, Division of Pulmonary & Critical Care Medicine
Professor of Internal Medicine
Director, Transplant Infectious Disease Service
Director, Infectious Diseases Fellowship Program
Visit the COVID-19 vaccine trial page on UMHealthResearch.org to learn more about the trial.
Visit UMHealthResearch.org to learn more about other coronavirus-related clinical research studies at the University of Michigan.
Reach out to the study team at AZVaccineStudy@med.umich.edu.